Cost-Effectiveness Analysis of Panitumumab+Mfolfox over Bevacizumab+Mfolfox as a First-Line Treatment for Metastatic Colorectal Cancer Patients with Wild-Type Ras in Greece

Affiliations

• ¹ National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
• ² Bioclinic Thessaloniki - Oncology Unit, Thesaloniki, Greece.
• ³ Laboratory of Tumor Cell Biology School of Medicine-University of Crete, Herakleion, Crete, Greece.
• ⁴ AMGEN Hellas, Marousi, Greece.
• ⁵ National School of Public Health, Athens, Greece.